Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05050110 · ClinicalTrials.gov registry record · NA

Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease

A NA study of Chronic Kidney Diseases, sponsored by Nand Wadhwa.

Active
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT05050110 is a NA study of Chronic Kidney Diseases that is active but no longer recruiting, run by Nand Wadhwa. The registered enrollment target is 13 participants, below the 445-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05050110, a NA study of Chronic Kidney Diseases, is active but no longer recruiting, sponsored by Nand Wadhwa.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

This study aims to investigate the feasibility of increasing dietary consumption of a rich variety of fruits and vegetables (including those that are potassim-rich) in patients with chronic kidney disease through use of nutritional counselling and hyperkalemia management with patiromer

Conditions Studied

Interventions

  • OTHER Fruits and Vegetable increase

Study Locations (1)

New York

  • NY Health - Port Jefferson Station

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2020-11-24
Est. Completion 2026-12
Phase NA

Sponsor

Nand Wadhwa

1 total trials

What the Registry Record Tells You About NCT05050110

The ClinicalTrials.gov registry entry for NCT05050110 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (97% lower). The listed sponsor is Nand Wadhwa, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Fruits and Vegetable increase is the first listed.

NCT05050110 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05050110 about?

NCT05050110 is a clinical study titled "Evaluation of Increased Fruits and Vegetables Consumption in Chronic Kidney Disease". This study aims to investigate the feasibility of increasing dietary consumption of a rich variety of fruits and vegetables (including those that are potassim-rich) in patients with chronic kidney disease through use of nutritional counselling and hyperkalemia management with patiromer

What is the current status of trial NCT05050110?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2020-11-24. Estimated completion is 2026-12.

What conditions does trial NCT05050110 study?

This clinical trial studies the following conditions: Chronic Kidney Diseases.

What interventions are being tested in trial NCT05050110?

The interventions under investigation include: Fruits and Vegetable increase (OTHER).

Who is sponsoring clinical trial NCT05050110?

This trial is sponsored by Nand Wadhwa, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05050110 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.